News Roche seizes chance for Tecentriq combo in first-line lung c... Roche chasing lucrative label extension.
News Clovis PARP drug gets fast US review in new ovarian cancer u... Impressed by survival data, FDA hastens review in expanded patient group
News MSD's new research centre a big boost for Brexit Britain But J&J set to snub the UK despite government Life Sciences strategy
News FDA approves Merck drug to prevent post-transplant infection... Prevymis approved either as pill or injection
News Merck & Co pulls Keytruda lung cancer filing in Europe Blow for Merck as Keytruda sales top $1 billion per quarter.
News BMS files Opdivo in post-surgery setting Opdivo performed better than BMS' Yervoy in clinical trial.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
